Heron Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.About HRTX
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034.
CEOCraig A. Collard
CEOCraig A. Collard
Employees122
Employees122
HeadquartersCary, North Carolina
HeadquartersCary, North Carolina
Founded1983
Founded1983
Employees122
Employees122
HRTX Key Statistics
Market cap246.62M
Market cap246.62M
Price-Earnings ratio-16.19
Price-Earnings ratio-16.19
Dividend yield—
Dividend yield—
Average volume1.83M
Average volume1.83M
High today$1.39
High today$1.39
Low today$1.29
Low today$1.29
Open price$1.29
Open price$1.29
Volume1.66M
Volume1.66M
52 Week high$2.68
52 Week high$2.68
52 Week low$0.9999
52 Week low$0.9999
Stock Snapshot
As of today, Heron Therapeutics(HRTX) shares are valued at $1.35. The company's market cap stands at 246.62M, with a P/E ratio of -16.19.
On 2025-12-30, Heron Therapeutics(HRTX) stock traded between a low of $1.29 and a high of $1.39. Shares are currently priced at $1.35, which is +4.3% above the low and -3.2% below the high.
The Heron Therapeutics(HRTX)'s current trading volume is 1.66M, compared to an average daily volume of 1.83M.
During the past year, Heron Therapeutics(HRTX) stock moved between $1.00 at its lowest and $2.68 at its peak.
During the past year, Heron Therapeutics(HRTX) stock moved between $1.00 at its lowest and $2.68 at its peak.
People also own
Based on the portfolios of people who own HRTX. This list is generated using Robinhood data, and it’s not a recommendation.